BPH Thermotherapy Device Competition Heats Up With TherMatrx Entry
This article was originally published in The Gray Sheet
Executive Summary
TherMatrx is hoping that the design of its TMx-2000 transurethral microwave thermotherapy system to treat benign prostatic hyperplasia - specifically, the absence of a cooling mechanism - will give it an edge over comparable devices on the market.
You may also be interested in...
AMS Plans PMA Supplement After TherMatrx Claims Draw FDA Scrutiny
American Medical Systems says it is preparing a PMA supplement that will include five-year follow-up data for the TherMatrx TMx-2000 BPH thermotherapy system
AMS Plans PMA Supplement After TherMatrx Claims Draw FDA Scrutiny
American Medical Systems says it is preparing a PMA supplement that will include five-year follow-up data for the TherMatrx TMx-2000 BPH thermotherapy system
Boston Scientific To Market Celsion’s Prolieve BPH Device Immediately
Boston Scientific will promote Celsion's Prolieve microwave urethroplasty system as a less-painful alternative to existing treatments for benign prostatic hyperplasia (BPH), following FDA approval Feb. 19